Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Biocon Biologics aggregated by PharmaCompass.com.

    Client Virtual Booth

    BIOCON BIOLOGICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Biocon Biologics
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    Biocon House, Semicon Park Electronics City, Phase – II, Hosur Road Bengaluru 560100, Karnataka
    Telephone
    Telephone
    +91 8067756775
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bioconbiologics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bioconbiologics/?originalSubdomain=in
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    EMA approves Biocon Biologics’ new mAbs facility in India
    EMA approves Biocon Biologics’ new mAbs facility in India

    https://www.indianpharmapost.com/news/ema-approves-biocon-biologics-new-mabs-facility-in-india-15796

    INDIANPHARMAPOST
    24 Jun 2024
    Share Share
    US FDA approves two biosimilars for blockbuster eye drug Eylea
    US FDA approves two biosimilars for blockbuster eye drug Eylea

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-biocon-units-biosimilar-blockbuster-eye-drug-eylea-2024-05-20/

    REUTERS
    21 May 2024
    Share Share
    Biocon Gets US Approval For Biosimilar Aflibercept Yesafili
    Biocon Gets US Approval For Biosimilar Aflibercept Yesafili

    https://www.prnewswire.com/news-releases/biocon-biologics-obtains-us-fda-approval-for-biosimilar-aflibercept-for-yesafili-enters-us-ophthalmology-market-302150830.html

    PR NEWSWIRE
    21 May 2024
    Share Share
    Biocon Biologics’ receives FDA approval for Biosimilar Aflibercept for Yesafili
    Biocon Biologics’ receives FDA approval for Biosimilar Aflibercept for Yesafili

    https://www.indianpharmapost.com/drug-approval/biocon-biologics-receives-fda-approval-for-biosimilar-aflibercept-for-yesafili-15666

    INDINPHARMAPOST
    21 May 2024
    Share Share
    USFDA approves Biocon Biologics' biosimilar product to treat ophthalmology
    USFDA approves Biocon Biologics' biosimilar product to treat ophthalmology

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-approves-biocon-biologics-biosimilar-product-to-treat-ophthalmology-conditions/articleshow/110293550.cms

    ECONOMICTIMES
    21 May 2024
    Share Share
    Biocon Biologics’ Yesafili (aflibercept-jbvf) Receives Approval In U.S
    Biocon Biologics’ Yesafili (aflibercept-jbvf) Receives Approval In U.S

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761274

    FDA
    20 May 2024
    Share Share
    Biocon Biologics gears up to challenge Stelara in the US
    Biocon Biologics gears up to challenge Stelara in the US

    https://www.fiercepharma.com/pharma/jj-settlement-biocon-biologics-gears-challenge-stelara-us

    Eric Sagonowsky FIERCE PHARMA
    29 Feb 2024
    Share Share
    Biocon Biologics focusing on market share gains of biosimilars in key markets
    Biocon Biologics focusing on market share gains of biosimilars in key markets

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biocon-biologics-focusing-on-market-share-gains-of-biosimilars-in-key-markets/articleshow/107659099.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    13 Feb 2024
    Share Share
    Biocon Concludes Integration of Biosimilars Business in 120 countries
    Biocon Concludes Integration of Biosimilars Business in 120 countries

    https://www.prnewswire.com/news-releases/biocon-biologics-concludes-integration-of-acquired-biosimilars-business-in-120-countries-302017727.html

    PR NEWSWIRE
    18 Dec 2023
    Share Share
    Biocon Biologics recognized as an Asia IP Elite for 2023
    Biocon Biologics recognized as an Asia IP Elite for 2023

    https://www.indianpharmapost.com/news/biocon-biologics-recognized-as-an-asia-ip-elite-for-2023-15016

    INDIAN PHARMA POST
    17 Dec 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    famar-2024-07-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search